Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Mestag Therapeutics Receives £1.5 million Grant from Innovate UK for Cancer Therapeutics Program

Aug 28, 2024•almost 2 years ago

Contract Type

partnership

LondonBiotechnology

Description

Mestag Therapeutics, based in Cambridge, United Kingdom, has been awarded a £1.5 million grant from Innovate UK’s Cancer Therapeutics program to accelerate the development of its MST-0300 antibody, which is designed to induce TLS in solid tumors. This partnership aims to advance next-generation immunotherapies for cancer and could revolutionize cancer treatment.

Company Information

Company

Mestag Therapeutics

Location

London, England, United Kingdom

About

Mestag Therapeutics is a biotech company harnessing new insights into fibroblast-immune interactions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Mestag Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.